MarkVSherridMD
Cardiology • New York, NYEchocardiography, Heart Failure & Transplantation
Program Director, Hypertrophic Cardiomyopathy Program
Dr. Sherrid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
425 W 59th St
New York, NY 10019Phone+1 212-492-5550Fax+1 212-492-5555
Education & Training
California Pacific Medical CenterFellowship, Cardiovascular Disease, 1978
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1973 - 1976
Columbia University Vagelos College of Physicians and SurgeonsClass of 1973
Certifications & Licensure
CA State Medical License 1975 - Present
NY State Medical License 1974 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years.Daniele Massera, Mark V Sherrid, Elizabeth Adlestein, Nadia Bokhari, Isabel C Alvarez
Journal of the American Heart Association. 2025-01-21 - Limited Concordance of Left Ventricular Ejection Fraction and Chamber Dimensions with Automated Assessments in Hypertrophic Cardiomyopathy: A Sub-study from VALOR-HCM.Gary Parizher, Alice Haouzi, Wael A Jaber, Anjali Owens, Kathy Wolski
Journal of the American Society of Echocardiography. 2024-12-27 - Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM.Milind Y Desai, Kathy Wolski, Anjali Owens, Jeffrey B Geske, Sara Saberi
Circulation. 2024-11-18
Journal Articles
- Myocardial Energy Depletion and Dynamic Systolic Dysfunction in Hypertrophic CardiomyopathyMark Sherrid, MD, Nature
Press Mentions
Talking Out About Women’s ‘Silent Killer’February 1st, 2019
Most States Don't Require AEDs in SchoolsMarch 27th, 2017
Few States Require AEDs in SchoolsMarch 27th, 2017- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
